Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 5—May 2016

Seroepidemiologic Screening for Zoonotic Viral Infections, Maputo, Mozambique

Eduardo Samo Gudo1, Birgitta Lesko1Comments to Author , Sirkka Vene, Nina Lagerqvist, Sandra Isabel Candido, Nilsa Razão de Deus, Félix Dinis Pinto, Gabriela Pinto, Vanessa Monteiro, Virginia Lara Evaristo, Nilesh Bhatt, Ivan Manhica, and Kerstin I. Falk
Author affiliations: Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique (E. Samo Gudo, S.I. Candido, N.R. de Deus, F. Pinto, G. Pinto, V. Monteiro, V.L. Evaristo, N. Bhatt); Public Health Agency of Sweden, Solna, Sweden (B. Lesko, S. Vene, N. Lagerqvist, K.I. Falk); Karolinska Institutet, Stockholm, Sweden (B. Lesko, K.I. Falk); National Directorate for Public Health, Ministry of Health, Mozambique (I. Manhica)

Main Article


Results of screening for viral antibodies and malaria parasites in 78 febrile patients, Maputo, Mozambique, 2012–2013*

Organism No. (%) positive†
Chikungunya virus 15 (19.2)
Dengue virus 10 (12.8)‡
Hantavirus 0
Rift Valley fever virus 1 (1.3)
West Nile virus 3 (3.8)
Malaria parasites 15 (19.2)§

*Viral antibody–positive patients had positive IgG or IgM response for >1 of the zoonotic viruses in acute- or convalescent-phase serum samples. The overall malaria screening results for the study cohort is also presented
†Three of the 23 serology-positive patients were positive for dengue virus and West Nile virus IgG, of whom 2 were also positive for chikungunya virus IgG and 1 for Rift Valley fever virus IgG.
‡Including 2 dengue virus IgM-positive samples.
§Three of 15 malaria-positive patients had a positive serologic finding (2 for dengue virus IgG and 1 for chikungunya IgG).

Main Article

1These authors contributed equally to this article.

Page created: April 14, 2016
Page updated: April 14, 2016
Page reviewed: April 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.